http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108752230-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
filingDate 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108752230-B
titleOfInvention Synthesis method of key intermediate of contrast agent iodixanol impurity E
abstract The invention discloses a synthesis method of a key intermediate of a contrast agent iodixanol impurity E, which takes 5-amino-N, N-bis (2, 3-dihydroxypropyl) -2,4, 6-triiodo-1, 3-benzenedicarboxamide as a raw material, takes water as a solvent, adds concentrated sulfuric acid, iodine and iodic acid, and reacts at a certain temperature; and cooling the reaction liquid, regulating the pH value, cooling, crystallizing, filtering, drying, further separating and purifying to obtain the high-purity target product 5-amino-N- (2, 3-dihydroxypropyl) -2,4, 6-triiodo-1, 3-benzenedicarboxamide. The iodic acid and iodine are added in the process to provide certain oxidizability and inhibit the deiodination reaction. And a small amount of concentrated sulfuric acid is added to provide an acidic environment and partial oxidation. In the preparation process of the compound III, the method of selecting and using the oxidant to react at high temperature under the acidic condition is simpler and more convenient compared with the method of introducing ammonia.
priorityDate 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013063737-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104768921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7754918-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103086915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102816085-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10395011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426123636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6931682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426158753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11802

Total number of triples: 34.